FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220940619> ?p ?o ?g. }

• W4220940619 endingPage "409" @default.
• W4220940619 startingPage "401" @default.
• W4220940619 abstract "Various prognostic factors have been reported for bone metastases from different primary tumor sites. However, bone metastases from colorectal cancer are very rare, and the prognostic factors have not been investigated in detail.This study aimed to identify prognostic factors of bone metastases from colorectal cancer.This is a retrospective cohort study using data from a prospectively collected database.This study was conducted at a single tertiary care cancer center in Japan.Patients who developed bone metastases from colorectal cancer during the study period among all patients who received initial treatment for colorectal cancer at our hospital between 2005 and 2016 (n = 4538) were included.Overall survival after diagnosis of bone metastases from colorectal cancer was the main outcome measure.Ninety-four patients developed bone metastases during the study period. The 5-year overall survival rate was 11.0%. Multivariable analysis identified the following independent risk factors associated with poor prognosis: ≥70 years of age at diagnosis of bone metastases (HR, 2.48; 95% CI, 1.24-4.95; p < 0.01), curative surgery not performed as initial treatment (HR, 2.54; 95% CI, 1.24-5.19; p = 0.01), multiple bone metastases (HR, 2.44; 95% CI, 1.30-4.57; p < 0.01), albumin level <3.7 g/dL (HR, 3.80; 95% CI, 1.95-7.39; p < 0.01), CEA ≥30 ng/mL (HR, 1.94; 95% CI, 1.09-3.46; p = 0.02), and less than 3 chemotherapy options remaining at diagnosis of bone metastases (HR, 2.83; 95% CI, 1.51-5.30; p < 0.01). The median survival times for patients with 0-2, 3, and 4-6 risk factors were 25.0, 8.8, and 4.3 months, respectively.The main limitation is the single-center, retrospective design of this study.Our results may facilitate multidisciplinary decision-making in patients with bone metastases from colorectal cancer. See Video Abstract at http://links.lww.com/DCR/B930 .ANTECEDENTES:Se han reportado varios factores pronósticos para las metástasis óseas de diferentes sitios de tumores primarios. Sin embargo, las metástasis óseas del cáncer colorrectal son muy raras y los factores pronósticos no se han investigado en detalle.OBJETIVO:Identificar los factores pronósticos de las metástasis óseas del cáncer colorrectal.DISEÑO:Estudio de cohorte retrospectivo utilizando datos de una base de datos recolectada prospectivamente.ENTORNO CLINICO:Un solo centro oncológico de atención terciaria en Japón.PACIENTES:Se seleccionaron pacientes que desarrollaron metástasis óseas de cáncer colorrectal durante el período de estudio entre todos los pacientes que recibieron tratamiento inicial para el cáncer colorrectal en nuestro hospital entre 2005 y 2016 (n = 4538).MEDIDA DE RESULTADO PRINCIPAL:Supervivencia general después del diagnóstico de metástasis óseas por cáncer colorrectal.RESULTADOS:Noventa y cuatro pacientes desarrollaron metástasis óseas, lo que representa el 2,0% de todos los pacientes con cáncer colorrectal que comenzaron el tratamiento durante el período de estudio. La tasa de supervivencia global a 5 años fue del 11,0 %. El análisis multivariable identificó los siguientes factores de riesgo independientes asociados con mal pronóstico: edad ≥70 años al momento del diagnóstico de metástasis óseas (hazard ratio 2,48, CI del 95 % 1,24-4,95, p < 0,01), cirugía curativa no realizada como tratamiento inicial (hazard ratio 2,54, CI 95 % 1,24-5,19, p = 0,01), metástasis óseas múltiples (hazard ratio 2,44, CI del 95 % 1,30-4,57, p < 0,01), nivel de albúmina <3,7 g/dL (hazard ratio 3,80, CI del 95 % 1,95 -7,39, p < 0,01), antígeno carcinoembrionario ≥30 ng/mL (hazard ratio 1,94, CI del 95 % 1,09-3,46, p = 0,02) y menos de 3 opciones de quimioterapia restantes al momento del diagnóstico de metástasis óseas (hazard ratio 2,83, 95 % CI 1,51-5,30, p < 0,01). La mediana de los tiempos de supervivencia para los pacientes con 0-2, 3 y 4-6 factores de riesgo fue de 25,0, 8,8 y 4,3 meses, respectivamente.LIMITACIONES:Diseño retrospectivo de un solo centro.CONCLUSIÓN:Nuestros resultados pueden facilitar la toma de decisiones multidisciplinares en pacientes con metástasis óseas de cáncer colorrectal. Consulte Video Resumen en http://links.lww.com/DCR/B930 . (Traducción- Dr. Francisco M. Abarca-Rendon )." @default.
• W4220940619 created "2022-04-03" @default.
• W4220940619 creator A5010090426 @default.
• W4220940619 creator A5020654087 @default.
• W4220940619 creator A5023337772 @default.
• W4220940619 creator A5028948975 @default.
• W4220940619 creator A5029454807 @default.
• W4220940619 creator A5051174536 @default.
• W4220940619 creator A5075160005 @default.
• W4220940619 creator A5080489308 @default.
• W4220940619 date "2022-03-01" @default.
• W4220940619 modified "2023-10-14" @default.
• W4220940619 title "Prognostic Factors of Bone Metastases From Colorectal Cancer in the Era of Targeted Therapy" @default.
• W4220940619 cites W1920947400 @default.
• W4220940619 cites W1979137823 @default.
• W4220940619 cites W1998066564 @default.
• W4220940619 cites W2028654075 @default.
• W4220940619 cites W2068649231 @default.
• W4220940619 cites W2076881443 @default.
• W4220940619 cites W2089726893 @default.
• W4220940619 cites W2115562378 @default.
• W4220940619 cites W2133557637 @default.
• W4220940619 cites W2134488474 @default.
• W4220940619 cites W2151364648 @default.
• W4220940619 cites W2151878651 @default.
• W4220940619 cites W2157416388 @default.
• W4220940619 cites W2167127503 @default.
• W4220940619 cites W2603476583 @default.
• W4220940619 cites W2604710163 @default.
• W4220940619 cites W2747294052 @default.
• W4220940619 cites W2765359666 @default.
• W4220940619 cites W2799387125 @default.
• W4220940619 cites W2886199343 @default.
• W4220940619 cites W2889646458 @default.
• W4220940619 cites W2902669007 @default.
• W4220940619 cites W2904314282 @default.
• W4220940619 cites W2905169933 @default.
• W4220940619 cites W2914896179 @default.
• W4220940619 cites W2921814635 @default.
• W4220940619 cites W2963887998 @default.
• W4220940619 cites W2965150666 @default.
• W4220940619 cites W3001411335 @default.
• W4220940619 cites W4211199921 @default.
• W4220940619 doi "https://doi.org/10.1097/dcr.0000000000002270" @default.
• W4220940619 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35239524" @default.
• W4220940619 hasPublicationYear "2022" @default.
• W4220940619 type Work @default.
• W4220940619 citedByCount "2" @default.
• W4220940619 countsByYear W42209406192023 @default.
• W4220940619 crossrefType "journal-article" @default.
• W4220940619 hasAuthorship W4220940619A5010090426 @default.
• W4220940619 hasAuthorship W4220940619A5020654087 @default.
• W4220940619 hasAuthorship W4220940619A5023337772 @default.
• W4220940619 hasAuthorship W4220940619A5028948975 @default.
• W4220940619 hasAuthorship W4220940619A5029454807 @default.
• W4220940619 hasAuthorship W4220940619A5051174536 @default.
• W4220940619 hasAuthorship W4220940619A5075160005 @default.
• W4220940619 hasAuthorship W4220940619A5080489308 @default.
• W4220940619 hasConcept C121608353 @default.
• W4220940619 hasConcept C126322002 @default.
• W4220940619 hasConcept C141071460 @default.
• W4220940619 hasConcept C143998085 @default.
• W4220940619 hasConcept C167135981 @default.
• W4220940619 hasConcept C2776694085 @default.
• W4220940619 hasConcept C2780140570 @default.
• W4220940619 hasConcept C526805850 @default.
• W4220940619 hasConcept C71924100 @default.
• W4220940619 hasConceptScore W4220940619C121608353 @default.
• W4220940619 hasConceptScore W4220940619C126322002 @default.
• W4220940619 hasConceptScore W4220940619C141071460 @default.
• W4220940619 hasConceptScore W4220940619C143998085 @default.
• W4220940619 hasConceptScore W4220940619C167135981 @default.
• W4220940619 hasConceptScore W4220940619C2776694085 @default.
• W4220940619 hasConceptScore W4220940619C2780140570 @default.
• W4220940619 hasConceptScore W4220940619C526805850 @default.
• W4220940619 hasConceptScore W4220940619C71924100 @default.
• W4220940619 hasIssue "3" @default.
• W4220940619 hasLocation W42209406191 @default.
• W4220940619 hasLocation W42209406192 @default.
• W4220940619 hasOpenAccess W4220940619 @default.
• W4220940619 hasPrimaryLocation W42209406191 @default.
• W4220940619 hasRelatedWork W2779530153 @default.
• W4220940619 hasRelatedWork W2954508456 @default.
• W4220940619 hasRelatedWork W3126136375 @default.
• W4220940619 hasRelatedWork W4224861992 @default.
• W4220940619 hasRelatedWork W4238067486 @default.
• W4220940619 hasRelatedWork W4240093402 @default.
• W4220940619 hasRelatedWork W4246054013 @default.
• W4220940619 hasRelatedWork W4295540420 @default.
• W4220940619 hasRelatedWork W4309413642 @default.
• W4220940619 hasRelatedWork W4323306248 @default.
• W4220940619 hasVolume "66" @default.
• W4220940619 isParatext "false" @default.
• W4220940619 isRetracted "false" @default.
• W4220940619 workType "article" @default.